2011
DOI: 10.1002/uog.8912
|View full text |Cite
|
Sign up to set email alerts
|

Hysterosalpingo‐foam sonography (HyFoSy): a new technique to visualize tubal patency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
35
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(35 citation statements)
references
References 11 publications
0
35
0
Order By: Relevance
“…[25] Demonstration of the lumen of tubes requires visualization of movement of fluid using highly echogenic medium. [26] Hyperechogenic contrast medium enhances echo signals and allows detection of the flow, both by B mode and Doppler ultrasound.…”
Section: Hycosymentioning
confidence: 99%
“…[25] Demonstration of the lumen of tubes requires visualization of movement of fluid using highly echogenic medium. [26] Hyperechogenic contrast medium enhances echo signals and allows detection of the flow, both by B mode and Doppler ultrasound.…”
Section: Hycosymentioning
confidence: 99%
“…The latter are ineffective and unnecessary, and only carry an unnecessary risk of cardiac complications and allergic reactions, respectively (Rijksen and Spaans, 2009). The safety profile of GIS and HyFoSy subsequently improved by omitting lidocaine and chorhexidine in the CE-marked gel (Emanuel and Exalto, 2011;Emanuel et al, 2012;Van den Bosch et al, 2011b;Van Schoubroeck et al, 2013). After more than 60,000 procedures with the gel, no allergic reactions or infections have been reported.…”
Section: Uterine Cavity Distensionmentioning
confidence: 89%
“…A combination of air and saline has been used as an alternative (Spalding et al, 1997). The development of HyFoSy with foam serves as an appropriate alternative for HyCoSy with Echovist (Bayer Schering Pharma AG) or saline (Emanuel and Exalto, 2011;Emanuel et al, 2012;Van Schoubroeck et al, 2013). HyFoSy with the foam also enables verification of correct placement of implants for sterilization like Essure (Bayer Healthcare AG, Leverkusen, Germany).…”
Section: Tubal Patency Testingmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2007, a non-embryo-toxic gel known as ExEm ® gel (GynaecologIQ) containing hydroxyethylcellulose and glycerol was introduced 10. The gel is diluted in water, and foam is mechanically created when this solution is pushed through narrow openings in syringes and tubes.…”
Section: Introductionmentioning
confidence: 99%